课题基金 / 基金详情

Tumor promotion effect by IL-1β gene transfer : Analysis of cancer-stromal interaction.

Tumor promotion effect by IL-1β gene transfer : Analysis of cancer-stromal interaction.
IL-1β 基因转移的肿瘤促进作用:癌症-基质相互作用的分析。
批准号:
11670563
负责人:
SAIJO Yasuo
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

SAIJO Yasuo的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Interleukin-1β (IL-1β) is a multifunctional and proinflamatory cytokine and affects nearly all cell type. In this study, we have constructed the retroviral vector expressing a hybrid gene of signal sequence and human IL-1β gene. Mouse Lewis lung carcinoma (LLC) cells were transduced with IL=1β gene (LLC/IL-1β). LLC/IL-1β accelerated tumor growth in mice despite of no change of growth property in vitro. Immunohistochemistry of CD31 in LLC/IL-1β tumor revealed hyper-neovascularization. LLC/IL-1β cells secreted larger amount of VEGF and MIP-2 whose one of main function is angigenesis. Moreover, LLC/IL-1β tumor contained over 4 times higher concentration of hepatocyte growth factor (HGF), although LLC/IL-1β cells itself did not secreted HGF in vitro. In situ hybridization of HGF mRNA demonstrated that stromal fibroblasts overexpressed HGF mRNA.An anti-angiogenic agent TNP-470 inhibited tumor growth of LLC/IL-1β cells. These results demonstrated that secreting IL-1β into tumor milieu induces several angiogenic factors from cancer and stromal cells and thus promotes tumor growth through neovascularization.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Masashi Tanaka, Yasuo Saijo, George Sato, Takuji Suzuki, Ryushi Tazawa, Ken Satoh, and Toshihiro Nukiwa.: "Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in Low Antigenic Lewis Lung Carcinoma."Cancer Gene Therapy. 7. 1
Masashi Tanaka、Yasuo Saijo、George Sato、Takuji Suzuki、Ryushi Tazawa、Ken Satoh 和 Toshihiro Nukiwa。:“在低抗原性路易斯肺癌中使用 IL-2 和 IL-12 联合免疫基因疗法诱导抗肿瘤免疫。”癌症基因
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka M,Narumi K,Isemura M,Abe M,Sato M,Saijo Y et al.: "Expression of the 37-kda laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis."Cancer Letters. 153. 161-167 (2000)
Tanaka M、Narumi K、Isemura M、Abe M、Sato M、Saijo Y 等人:“鼠肺肿瘤细胞中 37-kda 层粘连蛋白的表达与肿瘤血管生成相关。”《癌症快报》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Saijo Y.et al.: "Autologous high killing cytotoxic T lymphocytes against human lung cancer are induced using IL-1β, IL-2, IL-4, and IL-6"Clinical Cancer Research. 5. 1203-1209 (1999)
Saijo Y.等人:“使用IL-1β、IL-2、IL-4和IL-6诱导针对人肺癌的自体高杀伤性细胞毒性T淋巴细胞”临床癌症研究5. 1203-1209 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka M,Saijo Y,Sato G,Suzuki T,Tazawa R,Satoh K,Nukiwa T.: "Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic lewis lung carcinoma."Cancer Gene Therapy. 7. 1481-1490 (2000)
Tanaka M、Saijo Y、Sato G、Suzuki T、Tazawa R、Satoh K、Nukiwa T.:“在低抗原性刘易斯肺癌中使用 IL-2 和 IL-12 联合免疫基因治疗诱导抗肿瘤免疫。”癌症基因治疗
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    a study and new treatment of lung cancer stem cells
    • 批准号:
      20390229
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2008
    • 负责人:
      SAIJO Yasuo
    • 依托单位:
    Tumor-Targeting gene therapy and regeneration of injured lung by mssenchymal stem cells
    • 批准号:
      16390232
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      2004
    • 负责人:
      SAIJO Yasuo
    • 依托单位:
    Immuno-gene therapy for non-small lecclung cancer using innate immunity by NKG2D and its ligand.
    • 批准号:
      13670588
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      SAIJO Yasuo
    • 依托单位: